Has Wilburn Bolton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $52,293 in general payments to Wilburn Bolton, MD across 706 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wilburn Bolton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wilburn Bolton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wilburn Bolton, MD

Endocrinology, Diabetes & Metabolism · Mobile, ALNPI 1225267289

Payments from drug & device makers

$52,293in general payments, 2019–2025

Across 706 payments — averaging $74.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$19K
Lilly USA, LLC$16K
Amgen$6K
Xeris Pharmaceuticals, Inc.$3K
Novo Nordisk$2K
Bayer$736
plus $5K from 41 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	72	$19,301
Lilly USA, LLC	112	$16,419
Amgen(2 entities)	64	$6,008
Xeris Pharmaceuticals, Inc.	28	$3,046
Novo Nordisk	150	$1,862
Bayer	41	$736
Tandem Diabetes Care, Inc.	23	$572
Medtronic(2 entities)	24	$554
AstraZeneca	17	$527
Corcept Therapeutics	16	$402
Insulet Corporation	15	$379
Sanofi-aventis U.S. LLC	14	$257
Boehringer Ingelheim	15	$222
Actelion Pharmaceuticals US, Inc.	11	$180
Dexcom, Inc.	11	$168
BETA Bionics, Inc.	9	$160
Chiesi USA, Inc.	7	$155
United Therapeutics Corporation	7	$132
Novartis	5	$95
Mannkind Corporation	6	$91
Rochester Medical Corporation	4	$86
AbbVie	5	$84
Lifescan, Inc.	6	$82
Ultragenyx Pharmaceutical Inc.	4	$71
Amneal Pharmaceuticals LLC	4	$60
Sequel Med Tech, LLC	3	$57
Shire North American Group Inc	3	$51
Esperion Therapeutics, Inc.	3	$45
Neurocrine Biosciences, Inc.	2	$45
Sunovion Pharmaceuticals Inc.	3	$44
BD	2	$43
IBSA Pharma Inc.	2	$33
Nevro Corp.	1	$33
Pfizer	2	$31
Antares Pharma, Inc.	2	$30
Johnson & Johnson	2	$27
Regeneron Healthcare Solutions, Inc.	1	$26
Ipsen Biopharmaceuticals, Inc	1	$23
RGH Enterprises LLC	1	$23
Mallinckrodt Hospital Products Inc.	1	$21
Gilead	1	$20
GRT US Holding, Inc.	1	$18
Circassia Inc.	1	$17
Recordati_rare_diseases_inc.	1	$16
Radius Health, Inc.	1	$14
Merck	1	$13
E.r. Squibb & Sons, L.L.C.	1	$13

How this compares

$52,293 in reported general payments places this provider in the 75th percentile of 79 endocrinology, diabetes & metabolism providers in Alabama.

See all endocrinology, diabetes & metabolism providers in Alabama →

Medicare billing

Part B allowed, 2024

$105,957

Medicare patients

258

Services billed

2,796

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Mobile

Anita KemmerlyMobile$13K
Michael DavisMobile$12K
Heather FishelMobile$11K
Michael GalitzMobile$10K
Jocelyn HewittMobile$9K
Huey McDanielMobile$8K
Stephen DavisMobile$7K
Ross del FierroMobile$6K
Jessica BhathalMobile$6K
William GarveyBirmingham$3.8M

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →